REGN logo

REGN Cost of goods sold

annual cost of goods sold:

$2.45B+$206.90M(+9.22%)
December 31, 2024

Summary

  • As of today (August 20, 2025), REGN annual cost of goods sold is $2.45 billion, with the most recent change of +$206.90 million (+9.22%) on December 31, 2024.
  • During the last 3 years, REGN annual cost of goods sold has fallen by -$272.30 million (-10.00%).
  • REGN annual cost of goods sold is now -10.00% below its all-time high of $2.72 billion, reached on December 31, 2021.

Performance

REGN Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

quarterly cost of goods sold:

$665.30M+$74.10M(+12.53%)
June 30, 2025

Summary

  • As of today (August 20, 2025), REGN quarterly cost of goods sold is $665.30 million, with the most recent change of +$74.10 million (+12.53%) on June 30, 2025.
  • Over the past year, REGN quarterly cost of goods sold has increased by +$64.40 million (+10.72%).
  • REGN quarterly cost of goods sold is now -37.06% below its all-time high of $1.06 billion, reached on December 31, 2021.

Performance

REGN quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

TTM cost of goods sold:

$2.56B+$64.40M(+2.58%)
June 30, 2025

Summary

  • As of today (August 20, 2025), REGN TTM cost of goods sold is $2.56 billion, with the most recent change of +$64.40 million (+2.58%) on June 30, 2025.
  • Over the past year, REGN TTM cost of goods sold has increased by +$241.10 million (+10.39%).
  • REGN TTM cost of goods sold is now -9.43% below its all-time high of $2.83 billion, reached on March 31, 2022.

Performance

REGN TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

REGN Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.2%+10.7%+10.4%
3 y3 years-10.0%+79.1%+5.2%
5 y5 years+151.3%+99.0%+120.4%

REGN Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.0%+43.8%-3.8%+79.1%at high+44.8%
5 y5-year-10.0%+151.3%-37.1%+99.6%-9.4%+120.4%
alltimeall time-10.0%>+9999.0%-37.1%>+9999.0%-9.4%>+9999.0%

REGN Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$665.30M(+12.5%)
$2.56B(+2.6%)
Mar 2025
-
$591.20M(-14.5%)
$2.50B(+1.8%)
Dec 2024
$2.45B(+9.2%)
$691.50M(+12.8%)
$2.45B(+2.6%)
Sep 2024
-
$612.80M(+2.0%)
$2.39B(+3.1%)
Jun 2024
-
$600.90M(+9.7%)
$2.32B(+4.2%)
Mar 2024
-
$547.90M(-12.9%)
$2.23B(-0.4%)
Dec 2023
$2.24B(+31.6%)
$629.10M(+16.1%)
$2.24B(+5.8%)
Sep 2023
-
$541.80M(+6.7%)
$2.11B(+6.6%)
Jun 2023
-
$508.00M(-8.8%)
$1.98B(+7.4%)
Mar 2023
-
$557.00M(+9.9%)
$1.85B(+4.4%)
Dec 2022
$1.71B(-37.4%)
$507.00M(+23.5%)
$1.77B(-23.7%)
Sep 2022
-
$410.40M(+10.5%)
$2.32B(-4.8%)
Jun 2022
-
$371.50M(-22.5%)
$2.43B(-13.9%)
Mar 2022
-
$479.20M(-54.7%)
$2.83B(+3.8%)
Dec 2021
$2.72B(+100.9%)
$1.06B(+100.8%)
$2.72B(+30.9%)
Sep 2021
-
$526.40M(-31.2%)
$2.08B(+10.2%)
Jun 2021
-
$764.80M(+103.7%)
$1.89B(+29.5%)
Mar 2021
-
$375.40M(-9.5%)
$1.46B(+7.5%)
Dec 2020
$1.36B(+39.0%)
$414.80M(+24.5%)
$1.36B(+11.4%)
Sep 2020
-
$333.30M(-0.3%)
$1.22B(+4.7%)
Jun 2020
-
$334.30M(+22.3%)
$1.16B(+13.3%)
Mar 2020
-
$273.40M(-0.9%)
$1.03B(+5.2%)
Dec 2019
$975.40M(+67.5%)
$276.00M(-0.9%)
$975.40M(+13.5%)
Sep 2019
-
$278.40M(+40.7%)
$859.36M(+18.2%)
Jun 2019
-
$197.90M(-11.3%)
$726.77M(+11.1%)
Mar 2019
-
$223.10M(+39.5%)
$654.17M(+12.3%)
Dec 2018
$582.30M(+7.3%)
$159.96M(+9.7%)
$582.33M(+3.5%)
Sep 2018
-
$145.81M(+16.4%)
$562.62M(+0.7%)
Jun 2018
-
$125.30M(-17.2%)
$558.76M(-2.2%)
Mar 2018
-
$151.26M(+7.8%)
$571.50M(+5.3%)
Dec 2017
$542.53M(+34.1%)
$140.25M(-1.2%)
$542.53M(+7.2%)
Sep 2017
-
$141.95M(+2.8%)
$505.86M(+16.0%)
Jun 2017
-
$138.05M(+12.9%)
$435.98M(+11.2%)
Mar 2017
-
$122.28M(+18.1%)
$391.99M(-3.1%)
Dec 2016
$404.44M(-13.5%)
$103.58M(+43.7%)
$404.44M(-6.9%)
Sep 2016
-
$72.07M(-23.4%)
$434.60M(-11.7%)
Jun 2016
-
$94.06M(-30.2%)
$492.29M(-2.0%)
Mar 2016
-
$134.73M(+0.7%)
$502.37M(+7.4%)
Dec 2015
$467.62M(+81.5%)
$133.74M(+3.1%)
$467.62M(+14.8%)
Sep 2015
-
$129.76M(+24.6%)
$407.49M(+17.3%)
Jun 2015
-
$104.14M(+4.2%)
$347.33M(+14.8%)
Mar 2015
-
$99.98M(+35.8%)
$302.58M(+17.4%)
Dec 2014
$257.70M(+31.1%)
$73.61M(+5.8%)
$257.70M(+5.8%)
Sep 2014
-
$69.60M(+17.2%)
$243.50M(+9.1%)
Jun 2014
-
$59.40M(+7.8%)
$223.28M(+4.7%)
Mar 2014
-
$55.10M(-7.2%)
$213.20M(+8.5%)
Dec 2013
$196.56M(+61.9%)
$59.41M(+20.3%)
$196.56M(+11.0%)
Sep 2013
-
$49.38M(+0.1%)
$177.10M(+12.7%)
Jun 2013
-
$49.31M(+28.2%)
$157.20M(+13.0%)
Mar 2013
-
$38.46M(-3.7%)
$139.14M(+14.6%)
Dec 2012
$121.39M(+243.9%)
$39.95M(+35.5%)
$121.39M(+31.4%)
Sep 2012
-
$29.47M(-5.7%)
$92.36M(+29.0%)
Jun 2012
-
$31.26M(+50.9%)
$71.61M(+47.2%)
Mar 2012
-
$20.71M(+89.8%)
$48.65M(+37.8%)
Dec 2011
$35.30M
$10.91M(+25.1%)
$35.30M(+13.6%)
Sep 2011
-
$8.73M(+5.2%)
$31.07M(+12.5%)
Jun 2011
-
$8.30M(+12.7%)
$27.61M(+13.9%)
DateAnnualQuarterlyTTM
Mar 2011
-
$7.36M(+10.1%)
$24.24M(+11.3%)
Dec 2010
$21.78M(+36.7%)
$6.68M(+26.9%)
$21.78M(+6.7%)
Sep 2010
-
$5.27M(+6.8%)
$20.42M(+6.3%)
Jun 2010
-
$4.93M(+0.6%)
$19.21M(+8.4%)
Mar 2010
-
$4.90M(-7.9%)
$17.72M(+11.2%)
Dec 2009
$15.93M(+30.5%)
$5.32M(+31.0%)
$15.93M(+14.9%)
Sep 2009
-
$4.06M(+18.3%)
$13.87M(+7.7%)
Jun 2009
-
$3.43M(+10.2%)
$12.87M(+36.4%)
Mar 2009
-
$3.12M(-4.3%)
$9.44M(+49.3%)
Dec 2008
$12.21M(-46.3%)
$3.26M(+6.2%)
$6.32M(+106.2%)
Sep 2008
-
$3.07M(-19.9%)
$3.07M(-86.5%)
Dec 2006
$22.74M(-9.3%)
$3.83M(-43.4%)
$22.74M(-8.8%)
Sep 2006
-
$6.76M(+4.0%)
$24.94M(-1.7%)
Jun 2006
-
$6.50M(+15.0%)
$25.36M(+4.1%)
Mar 2006
-
$5.65M(-6.2%)
$24.36M(-2.8%)
Dec 2005
$25.06M(-83.4%)
$6.03M(-16.1%)
$25.06M(-56.3%)
Sep 2005
-
$7.18M(+30.4%)
$57.30M(-37.7%)
Jun 2005
-
$5.51M(-13.3%)
$91.93M(-25.4%)
Mar 2005
-
$6.35M(-83.4%)
$123.25M(-18.5%)
Dec 2004
$151.31M(+1051.1%)
$38.26M(-8.5%)
$151.31M(+2.8%)
Sep 2004
-
$41.81M(+13.5%)
$147.22M(+1.6%)
Jun 2004
-
$36.83M(+7.0%)
$144.90M(+2.0%)
Mar 2004
-
$34.41M(+0.7%)
$142.05M(-0.5%)
Dec 2003
$13.14M(+22.7%)
$34.17M(-13.5%)
$142.70M(-1.4%)
Sep 2003
-
$39.49M(+16.2%)
$144.71M(+2.5%)
Jun 2003
-
$33.98M(-3.1%)
$141.14M(+1.0%)
Mar 2003
-
$35.06M(-3.1%)
$139.73M(+6.3%)
Dec 2002
$10.71M(+64.5%)
$36.18M(+0.7%)
$131.41M(+3.9%)
Sep 2002
-
$35.93M(+10.3%)
$126.49M(+8.2%)
Jun 2002
-
$32.56M(+21.8%)
$116.87M(+10.5%)
Mar 2002
-
$26.73M(-14.5%)
$105.79M(+7.9%)
Dec 2001
$6.51M(-67.4%)
$31.26M(+18.8%)
$98.05M(+46.8%)
Sep 2001
-
$26.31M(+22.5%)
$66.79M(+14.7%)
Jun 2001
-
$21.48M(+13.1%)
$58.23M(+8.9%)
Mar 2001
-
$18.99M(+7.0%)
$53.46M(-13.5%)
Dec 2000
$19.99M(+184.0%)
-
-
Sep 2000
-
$17.75M(+6.2%)
$61.80M(+4.9%)
Jun 2000
-
$16.72M(+4.8%)
$58.91M(+7.1%)
Mar 2000
-
$15.95M(+40.2%)
$55.00M(+5.3%)
Dec 1999
$7.04M(-12.3%)
$11.38M(-23.4%)
$52.25M(+27.8%)
Sep 1999
-
$14.86M(+16.0%)
$40.87M(+41.6%)
Jun 1999
-
$12.81M(-2.9%)
$28.87M(+6.4%)
Mar 1999
-
$13.20M(+361.9%)
$27.13M(+9.8%)
Dec 1998
$8.02M(+14.5%)
-
-
Sep 1998
-
$2.86M(-74.2%)
$24.71M(+9.1%)
Jun 1998
-
$11.07M(+12.0%)
$22.66M(+87.4%)
Mar 1998
-
$9.89M(+998.6%)
$12.09M(+347.7%)
Dec 1997
$7.01M(-2.7%)
$900.00K(+12.5%)
$2.70M(+50.0%)
Sep 1997
-
$800.00K(+60.0%)
$1.80M(+80.0%)
Jun 1997
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1997
-
$500.00K(-95.3%)
$500.00K(-95.3%)
Dec 1996
$7.20M(+241.2%)
-
-
Sep 1993
-
$10.60M(+112.0%)
$10.60M(+2.9%)
Dec 1992
$2.11M(+170.8%)
-
-
Dec 1991
$779.10K(-87.6%)
$5.00M(+108.3%)
$10.30M(+94.3%)
Sep 1991
-
$2.40M(-17.2%)
$5.30M(+82.8%)
Jun 1991
-
$2.90M
$2.90M
Dec 1990
$6.30M
-
-

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual cost of goods sold?

The current annual cost of goods sold of REGN is $2.45B

What is the all time high annual cost of goods sold for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual cost of goods sold is $2.72B

What is Regeneron Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?

Over the past year, REGN annual cost of goods sold has changed by +$206.90M (+9.22%)

What is Regeneron Pharmaceuticals, Inc. quarterly cost of goods sold?

The current quarterly cost of goods sold of REGN is $665.30M

What is the all time high quarterly cost of goods sold for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly cost of goods sold is $1.06B

What is Regeneron Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?

Over the past year, REGN quarterly cost of goods sold has changed by +$64.40M (+10.72%)

What is Regeneron Pharmaceuticals, Inc. TTM cost of goods sold?

The current TTM cost of goods sold of REGN is $2.56B

What is the all time high TTM cost of goods sold for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high TTM cost of goods sold is $2.83B

What is Regeneron Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

Over the past year, REGN TTM cost of goods sold has changed by +$241.10M (+10.39%)
On this page